Arbutus Biopharma Corp (ABUS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
09:36 am
Sale
2021-12-3113GARBUTUS BIOPHARMA CORP
ABUS
RTW Investments, LP2,504,493
1.700%
-3,473,862decrease
(-58.11%)
Filing
History
2021-10-20
5:13 pm
Purchase
2021-10-1813DARBUTUS BIOPHARMA CORP
ABUS
Roivant Sciences Ltd.
ROIV
38,847,462
29.100%
22,833,922increase
(+142.59%)
Filing
History
Goto Prev, 0, 1